Key Finding
Cupping therapy was associated with an 83% higher likelihood of treatment success in migraine patients (RR 1.83, 95% CI: 1.52–2.21), with wet cupping demonstrating the strongest effect.
Migraines can be debilitating, and many people are turning to complementary therapies for relief. A new scientific review published in the Journal of Pharmacopuncture took a close look at whether cupping therapy — an ancient practice that uses suction cups on the skin — can genuinely help people who suffer from migraine headaches.
Researchers analyzed 18 clinical trials involving 1,446 participants, making this one of the most comprehensive reviews on the topic to date. Nearly 800 of those participants received cupping therapy, allowing scientists to draw meaningful comparisons.
The results were encouraging. People who received cupping therapy were 83% more likely to experience treatment success compared to those who did not. Cupping also significantly reduced pain intensity during treatment. Notably, wet cupping — a technique where small amounts of blood are drawn through the skin after suction — showed the strongest results for treatment success.
The review also found that cupping carried a lower risk of adverse events, meaning it appears to be a relatively safe option for most people. One area where cupping fell short, however, was in improving overall quality of life as measured by the Migraine Disability Scale. Researchers suggest this may reflect the need for longer treatment periods or combined approaches.
What does this mean if you suffer from migraines? Cupping therapy shows real promise as a complementary tool — meaning it can work alongside your existing treatments, not necessarily replace them. It won't work for everyone, but the evidence suggests it is both safe and effective for reducing migraine pain and improving treatment outcomes.
If you are curious about cupping therapy for migraines, speak with a licensed acupuncturist or traditional Chinese medicine practitioner who can assess whether it is appropriate for your individual health needs.
This systematic review and meta-analysis (PROSPERO CRD42024514509) evaluated 18 RCTs pooling 1,446 participants (n=797 cupping) across seven databases to assess cupping therapy's efficacy and safety in migraine headache disorder. Primary endpoints included treatment success and pain intensity reduction; secondary endpoints were adverse events (AEs) and quality of life via MIDAS.
Cupping therapy demonstrated significantly higher treatment success rates (RR 1.83, 95% CI: 1.52–2.21) and meaningful pain reduction versus baseline (SMD 0.55, 95% CI: 0.39–0.70). Subgroup analysis identified wet cupping as the primary driver of treatment success (RR 1.88, 95% CI: 1.53–2.30). Adjunctive modalities — including acupuncture and collateral pricking — did not significantly amplify outcomes beyond cupping monotherapy. AE risk was favorable for cupping. However, no statistically significant improvement in QoL (MIDAS SMD -0.79, 95% CI: -3.55–1.98) was observed.
Clinical takeaway: Wet cupping represents a clinically viable, low-risk adjunct for migraine management, though QoL improvements may require longer treatment protocols or multimodal integration.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Acupuncture reduces migraine symptoms in rat models primarily by suppressing CGRP, substance P, and 5-HT neurotransmitters, inhibiting microglial activation, and modulating the descending pain modulatory system to reduce neurogenic inflammation and central sensitization.
📌 A non-linear dose-response analysis found that 16 acupuncture sessions delivered three times per week over approximately two months produced the greatest reduction in migraine attack frequency, with diminishing benefits beyond this threshold.
📌 A bibliometric analysis of 1,129 migraine clinical trials published over 20 years identified CGRP-targeted therapies, comorbidity research, and real-world effectiveness as the dominant emerging trends shaping the future of migraine management.